Intrathecal baclofen treatment in dystonic cerebral palsy: a randomized clinical trial: the IDYS trial

BACKGROUND: Dystonic cerebral palsy is primarily caused by damage to the basal ganglia and central cortex. The daily care of these patients can be difficult due to dystonic movements. Intrathecal baclofen treatment is a potential treatment option for dystonia and has become common practice. Despite...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bonouvrié, Laura A, Becher, Jules G, Vles, Johannes SH, Boeschoten, Karin, Soudant, Dan, de Groot, Vincent, van Ouwerkerk, Willem JR, Strijers, Rob LM, Foncke, Elisabeth, Geytenbeek, Joke, van de Ven, Peter M, Teernstra, Onno, Vermeulen, R Jeroen
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3840690/
https://ncbi.nlm.nih.gov/pubmed/24165282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2431-13-175
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados